Would Pfizer Shareholders Win With an Acquisition of Amarin?

Perhaps the juiciest gossip right now relates to a potential acquisition of Amarin (NASDAQ:AMRN) by Pfizer (NYSE:PFE). Nine days ago, StreetInsider.com reported that Pfizer could be looking to buy Amarin.